结质母细胞瘤的性别相关差异:一个单一中心的回顾性队列研究
Chiara Prosperetti1,2, Meltem Yenigün3, Alberto Pagnamenta4
1Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
Biomedicines
|July 29, 2025
概括
性别影响质母细胞瘤 (GB) 瘤的特征和治疗. 女性表现出更高的多焦点性和EGFR放大,而男性接受更多的化疗和放射治疗,影响患者的治疗结果.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 基因组学就是基因组学.
背景情况:
- 性差异影响质母细胞瘤 (GB) 流行病学,生物学和结果.
- GB在男性中更常见,但女性的生存时间往往更长.
- 荷尔蒙影响,风险因素和治疗差异可能解释这些差异.
研究的目的:
- 评估基于性别的质母细胞瘤瘤特征和患者结局的差异.
- 确定质母细胞瘤患者进展时间和死亡率的预测因素.
- 通过了解性别特异性模式,为个性化治疗策略提供信息.
主要方法:
- 对神经瘤数据库的回顾性分析,重点关注质母细胞瘤 (GB) 病例.
- 收集的数据包括性别,年龄,瘤类型,分子生物标志物和治疗方式.
- 评估瘤特征和结果的基于性别的差异;确定死亡率和进展预测因素.
主要成果:
- 在年龄或瘤类型分布方面没有显著的性别差异.
- 患有GB的女性表现出多焦点和EGFR放大更高的患病率.
- 男性更频繁地接受化疗和放射治疗;TERT突变和多焦点性预测了较差的结果.
结论:
- 性别和分子分析对质母细胞瘤 (GB) 管理至关重要.
- 在男性和女性GB患者之间存在瘤特征和治疗的不同模式.
- 整合性别特异性考虑和分子数据可以改善GB患者的治疗结果.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...